Zimmer Biomet Holdings Stock News

Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth quarter, compared to $0.31 in

Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 2 8 2 0 L

Zimmer Biomet Holdings (NYSE: ZBH ) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 2 8 2 0 Last 30D 0 0 1 0 0 1M Ago 3 2 4 1 0 2M Ago 1 0 2 1 0 3M Ago 3 0 1 0 0 According to 19 analyst offering 12-month price targets in the last 3 months, Zimmer Biomet Holdings has an average price target of $136.84 with a high of $165.00 and a low of $111.00. Below is a summary of how these 19 analysts rated Zimmer Biomet Holdings over the past 3 months. … Full story available on Benzinga.com

New York, USA, March 01, 2022 (GLOBE NEWSWIRE) -- The Global Powered Surgical Instruments Market Is Expected To Exhibit Strong Growth With a CAGR of 4.26% In The Coming Years , Assess DelveInsight As per DelveInsight analysis, the Powered Surgical Instruments market is growing positively due to the factors such as an increase in geriatric population, having a high prevalence of bone disorders and ophthalmic conditions, and along with the increasing incidence of brain cancers as well increase in the number of trauma cases, and a parallel growth in product innovation. DelveInsight''s Powered Surgical Instruments Market Insights report provides the current and forecast Powered Surgical Instruments market, upcoming device innovation, individual leading Powered Surgical Instruments device companies market shares, challenges, drivers, barriers, and market trends and key Powered Surgical Instruments companies in the market. Key Takeaways from the Global Powered Surgical Instruments Market According to DelveInsight analysis, North America is expected to dominate the overall Powered Surgical Instruments market during the forecast period.

New York, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Minimally Invasive Surgical Systems Market: Focus on Product Type, Application, End Users, 25 Countries'' Data, Patent Scenario, and Competitive Landscape - Analysis and Forecast, 2021-2031" - https://www.reportlinker.com/p06135349/?utm_source=GNW Market Segmentation • Product - Conventional Technologies (Endoscopes and Endoscopic Systems, Video and Visualization Systems, Capsule Endoscopy, Instruments and Accessories, Others), Surgical Robotics (Robotic Systems, Instruments and Accessories, Services) • Application - General Surgery, Urology Surgery, Gynecology Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, Others • End User - Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics • Region - North America, Europe, Asia-Pacific, Latin America, Middle East and Africa Regional Segmentation • North America - U.S., Canada • Europe - Germany, France, Spain, U.

Zimmer Biomet Holdings found using ticker (ZBH) now have 23 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 180 and 102 with the average target price sitting at 133.35. Now with the previous closing price of 123.48 this would imply there is a potential upside of 8.0%. The 50 day MA is 123.56 while the 200 day moving average is 142.75. The company has a market cap of $26,506m. Visit the company website at: https://www.zimmerbiomet.com [stock_market_widget type="chart" template="basic" color="green" assets=ZBH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $28,624m based on the market concensus. Zimmer Biomet Holdings, together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) declares $0.24/share quarterly dividend, line with previous.Forward yield 0.79%Payable April 29; for shareholders of record March 29; ex-div March

DUBLIN--(BUSINESS WIRE)--The "Global Surgical Robots Market" report has been added to ResearchAndMarkets.com''s offering. The global surgical robots market was valued at $8052.67 Million in the year 2020 with North America region leading the regional market share. Companies Mentioned Intuitive Surgical Stryker Corporation Medtronic Smith & Nephew Zimmer Biomet Accuray Incorporated Renishaw Asensus Surgical Medrobotics Corporation Think Surgical The market is projected to display momentous gr

New York, USA, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Global Orthobiologics Market is Anticipated to Grow at a CAGR of 4.44% During the Forecast Period (2021-26) | DelveInsight As per DelveInsight analysis, a growing geriatric population at risk of developing various bone degenerative disorders, an increase in traumatic injuries such as car accidents, sports injuries, and others are expected to boost the Orthobiologics market growth. Furthermore rising investments in R&D and collaborations by key manufacturers, as well as an increase in various orthobiologic product approvals will also drive the market. DelveInsight''s Orthobiologics Market Insights and Forecast report provides the current and forecast Orthobiologics market, upcoming developments in the medical devices, individual market shares, challenges, drivers, barriers, market growth trends, and key players in the Orthobiologics market. Some of the Key Highlights from the Orthobiologics Market Report According to DelveInsight analysis, North America is expected to dominate the overall Orthobiologics Market during the forecasted period.

The "Implantable Biomaterials Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. This report provides the strategists, marketers and senior management with the critical information they need to assess the global implantable biomaterials market. The global implantable biomaterials market is expected to grow from $103.9 billion in 2020 to $114.35 billion in 2021 at a compound annual growth rate (CAGR) of 10.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $161.22 billion in 2025 at a CAGR of 9%. Companies Mentioned Evonik Industries AG Royal DSM Zimmer Biomet Holdings Carpenter Technology Corporation Collagen Matrix Corbion BASF SE Invibio Ltd.

According to Zimmer Biomet (ZBH), severe customer staffing shortages and a more-than-anticipated impact of China VBP lead to dismal Q4 revenues.

According to Zimmer Biomet (ZBH), severe customer staffing shortages and a more-than-anticipated impact of China VBP lead to dismal Q4 revenues.

On February 7, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported earnings for the fourth quarter, posting an EPS of $1.95, missing estimates by $0.03. Zimmer Biomet Holdings, Inc.

Zimmer Biomet (ZBH) CEC will function as the interface between healthcare professionals and the company through engaging and interactive training across all product portfolios.

Zimmer Biomet (ZBH) CEC will function as the interface between healthcare professionals and the company through engaging and interactive training across all product portfolios.